Birgitta Versluijs

123 Respiratory virus infection pre-HCT and alloimmune-mediated lung syndromes monia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network pro- tocol. Biol Blood Marrow Transplant 2014;20:858-64. 14. Campbell AP, Guthrie KA, Englund JA, Farney RM, Minerich EL, Kuypers J, et al. Clinical outcomes associated with respiratory virus detection before allo- geneic hematopoietic stem cell trans- plant. Clin Infect Dis 2015;61:192-202. 15. Srinivasan A, Flynn P, Gu Z, Hartford C, Lovins R, Sunkara A, et al. Detection of respiratory viruses in asymptomatic children undergoing allogeneic hema- topoietic cell transplantation. Pediatr Blood Cancer 2013;60:149-51. 16. Gerna G, Piralla A, Rovida F, Rognoni V, Marchi A, Locatelli F, et al. Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocom- promised patients. J Med Virol 2009;81: 1498-507. 17. Hutspardol S, Essa M, Richardson S, Schechter T, Ali M, Krueger J, et al. Significant transplantation-related mor- tality from respiratory virus infections within the first one hundred days in children after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015;21:1802-7. 18. Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on In- fections in Leukaemia (ECIL-4): gui- delines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013;56:258-66. 19. Bredius RG, Templeton KE, Scheltinga SA, Claas EC, Kroes AC, Vossen JM. Prospective study of respiratory viral in- fections in pediatric hemopoietic stem cell transplantation patients. Pediatr In- fect Dis J 2004;23:518-22. 20. Seo S, Martin E, Xie H, Kuypers J, Campbell AP, Choi SW, et al. Human rhinovirus RNA detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality. Biol Blood Marrow Transplant 2013;19(suppl):S167-77. 21. Cadwell K. The virome in host health and disease. Immunity 2015;42:805-13. 22. Tracy M, Cogen J, Hoffman LR. The pe- diatric microbiome and the lung. Curr Opin Pediatr 2015;27:348-55. 23. Lynch SV. Viruses and microbiome al- terations. Ann Am Thorac Soc 2014; 11(suppl 1):S57-60. 24. Holtan SG, Pasquini M, Weisdorf DJ. Acute graft-versus-host disease: a bench-to-bedside update. Blood 2014; 124: 363-73. 25. Brennan TV, Rendell VR, Yang Y. Innate immune activation by tissue injury and cell death in the setting of hematopoie- tic stem cell transplantation. Front Im- munol 2015;6:101. 26. Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev 2003;17:187-94. 27. Kumar D, Husain S, Chen MH, Mous- sa G, Himsworth D, Manuel O, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplan- tation 2010;89:1028-33. 28. Fisher CE, Preiksaitis CM, Lease ED, Edelman J, Kirby KA, Leisenring WM, et al. Symptomatic respiratory virus infec- tion and chronic lung allograft dysfunc- tion. Clin Infect Dis 2016;62:313-9. 29. Vu DL, Bridevaux PO, Aubert JD, Soc- cal PM, Kaiser L. Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies. Am J Transplant 2011;11:1071-8. 7